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Gene regulationN-Methyl-D-aspartate (NMDA) receptors are major glutamatergic receptors involved in most excitatory neuro-
transmission in the brain. The transcriptional regulation of NMDA receptors is not fully understood. Previously,
we found that the GluN1 and GluN2B subunits of the NMDA receptor are regulated by nuclear respiratory factors
1 and 2 (NRF-1 and NRF-2). NRF-1 and NRF-2 also regulate all 13 subunits of cytochrome c oxidase (COX), a
critical energy-generating enzyme, thereby coupling neuronal activity and energy metabolism at the transcrip-
tional level. Speciﬁcity protein (Sp) is a family of transcription factors that bind to GC-rich regions, with Sp1,
Sp3, and Sp4 all binding to the same cis-motifs. Sp1 and Sp3 are ubiquitously expressed, whereas Sp4 expression
is restricted to neurons and testicular cells. Recently, we found that the Sp1 factor regulates all subunits of COX.
The goal of the present study was to test our hypothesis that the Sp factors also regulate speciﬁc subunits of
NMDA receptors, and that they function with NRF-1 and NRF-2 via one of three mechanisms: complementary,
concurrent and parallel, or a combination of complementary and concurrent/parallel. By means of multiple
approaches we found that Sp4 functionally regulated GluN1, GluN2A, and GluN2B, but not GluN2C. On the
other hand, Sp1 and Sp3 did not regulate these subunits as previously thought. Our data suggest that Sp4
operates in a complementary and concurrent/parallel manner with NRF-1 and NRF-2 to mediate the tight
coupling between energy metabolism and neuronal activity at the molecular level.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
N-Methyl-D-aspartate (NMDA) receptors are excitatory glutama-
tergic receptors ubiquitously expressed in the brain. They play critical
roles in processes ranging from basic excitatory neurotransmission to
the complex phenomenon of synaptic plasticity, learning, and memory
(for review see [1]). NMDA receptors are heterotetrameric, voltage-
dependent, ligand-gated ion channels composed of the ubiquitous
GluN1 subunit in various combinations with the GluN2A–D, or
GluN3A–B subunits [2]. The properties of NMDA receptors are dictated
by their subunit composition, with the majority composed of two
GluN1 and two GluN2A or GluN2B subunits [3]. The GluN1/GluN2A
receptors, expressed predominantly in the adult brain, are faster-
acting than the GluN1/GluN2B receptors, which are widely expressed
in both the adult and neonatal brains [2]. The GluN2C, GluN2D,
GluN3A, and GluN3B receptor subunits are more developmentally and
regionally speciﬁed [4,5].
Our laboratory has shown that GluN1 and GluN2B are transcrip-
tionally regulated by nuclear respiratory factors 1 (NRF-1) and 2
(NRF-2) via a concurrent and parallel mechanism [6,7]. NRF-1 andtor; Grin, Gene name for NMDA
1 414 955 6517.
ights reserved.NRF-2 each also regulates all 13 subunits of cytochrome c oxidase
(COX), an enzyme critical for energy generation in neurons [8–10].
Neuronal activity and energymetabolism are tightly coupled. A require-
ment for NRF-1 and NRF-2 in this coupling is revealed when a reduction
in the expression of COX, GluN1, and GluN2B induced by TTX blockade
is rescued by an over-expression of NRF-1 and NRF-2, and an up-
regulation of these proteins induced by KCl depolarization is suppressed
by a knock-down of NRF-1 or NRF-2 [6,7,9,10]. The question arises as
to whether other transcription factors are also involved in this co-
regulation.
Speciﬁcity protein (Sp) is a family of zinc-ﬁnger transcription factors
that binds to GC-rich regulatory regions of genes [11]. Three members,
namely Sp1, Sp3, and Sp4, possess two glutamine-rich domains that
bind and compete for the same cis- motifs: the GC box ‘GGGCGG’ with
high afﬁnity, or the GT and CT boxes with signiﬁcantly lower afﬁnities
(‘GGGTGG’ and ‘CCCTCC’, respectively) [11,12]. Sp1 and Sp3 are ubiqui-
tously expressed and are involved in a wide variety of cellular processes
[13]. Unlike Sp1 and Sp3, the expression of Sp4 is restricted to neurons
and testicular cells [14].
Recently, we found that Sp1 factor, like NRF-1 and NRF-2, transcrip-
tionally regulates all subunit genes of COX [15].We sought to determine
if Sp1, Sp3, and/or Sp4 regulate speciﬁc subunits of NMDA receptors. If
so, do these transcription factors operate via complementary, concur-
rent and parallel, or a combined complementary and concurrent/parallel
mechanism with NRF-1 and NRF-2? In the complementary mechanism,
Table 1A
EMSA probes. Positions of probes are given relative to TSP. Putative Sp1 binding sites are
underlined.
Gene promoter Position EMSA sequence
Grin1 −208/−188 F: 5′ TTTTGGAAGCGGGGGCGGTGGGAGG 3′
R: 5′ TTTTCCTCCCACCGCCCCCGCTTCC 3′
Grin2a +46/+67 F: 5′ TTTTGCATCCTGGGCGGGTGTGTGC 3′
R: 5′ TTTTGCACACACCCGCCCAGGATGC 3′
Grin2b +155/+174 F: 5′ TTTTGATGTCCCCGCCCTCCCCGC 3′
R: 5′ TTTTGCGGGGAGGGCGGGGACATC 3′
Grin2c −56/−32 F: 5′ TTTTCGGCTGGGGCGGGCCGGGGCGGGGC 3′
R: 5′ TTTTGCCCCGCCCCGGCCCGCCCCAGCCG 3′
GM3 synthase −58/−38 F: 5′ TTTTGCGCGACCCCGCCCCCGCCTA 3′
R: 5′ TTTTTAGGCGGGGGCGGGGTCGCGC 3′
Table 1B
Mutant EMSA probes. Positions of probes are given relative to TSP. Mutated Sp1 binding
sites are underlined.
Gene promoter Position Sequence
Grin1 −208/−188 F: 5′ TTTTGGAAGCGTTTTTTGTGTGAGG 3′
R: 5′ TTTTCCTCACACAAAAAACGCTTCC 3′
Grin2a +46/+67 F: 5′ TTTTGCATCCTAAACAAATGTGTGC 3′
R: 5′ TTTTGCACACATTTGTTTAGGATGC 3′
Grin2b +155/+174 F: 5′ TTTTGATGTCTTTTTTCTTTTCGC 3′
R: 5′ TTTTGCGAAAAGAAAAAAGACATC 3′
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regulated by NRF-1 and NRF-2. In the concurrent and parallel mecha-
nism, Sp factors, NRF-1, and NRF-2 jointly regulate the same NMDA
receptor subunit genes in a parallel fashion (both are stimulatory). In a
combination of the complementary and concurrent/parallel mecha-
nisms, a subset of subunit genes is controlled by all three factors,
whereas a different subset is controlled by Sp factors but not NRF-1
or NRF-2.
The goal of the present study was to test our hypothesis that Sp1,
Sp3, and Sp4 also mediate the transcriptional coupling of synaptic
transmission and energy metabolism.
2. Material and methods
All experiments and animal procedures were performed in
accordance with the Guide for the Care and Use of Laboratory
Animals (National Institutes of Health Publications No. 80-23,
revised 1996), and all protocols were approved by the Medical
College of Wisconsin Animal Care and Use Committee (approval
can be provided upon request). All efforts were made to minimize
the number of animals used and their suffering.
2.1. Cell culture
Murine neuroblastoma (N2a) cells (ATCC, Manassas, VA, USA) were
grown in Dulbecco's modiﬁed Eagle's medium supplemented with 10%
fetal bovine serum, 50 units/mL penicillin, and 100 μg/mL streptomycin
(Invitrogen, Carlsbad, CA, USA) at 37 °C in a humidiﬁed atmosphere
with 5% CO2.
Mouse primary visual cortex neurons were cultured as described
previously for rats [16]. Brieﬂy, 1-day-old neonatal mouse pups were
killed by decapitation. Brains were removed from the skull and the
meninges were removed. Cortical tissue was dissected, trypsinized,
and triturated to release individual neurons. Primary cortical neurons
were plated in 35 mm poly-L-lysine-coated dishes at a density of
200,000 cells/dish. Cells were maintained in Neurobasal-A media
supplemented with B27 (Invitrogen). Ara-C (Sigma, St Louis, MO,
USA) was added to the media to suppress the proliferation of glial cells.
2.2. In silico analysis of promoters of murine NMDA receptor subunit genes
DNA sequences surrounding the transcription start points (TSPs) of
N-methyl-D-aspartate (NMDA) receptor subunit genes (Grin1 and
Grin2a–c) were derived from the NCBI mouse genome database (Grin1
GenBank ID: NC_000068.7, Grin2a GenBank ID: NC_000082.6, Grin2b
GenBank ID: NC_000072.6, Grin2c GenBank ID: NC_000077.6). Se-
quences encompassing 1 kb upstream and 1 kb downstream of the TSP
of each gene were analyzed. Computer-assisted search for Sp1 binding
motif ‘GGGCGG’, or the atypical Sp1 binding motif ‘GGGTGG’, or their
complements, was conducted on each promoter. These motifs were
applicable to Sp1, Sp3, or Sp4.
Alignment of human, mouse, and rat promoter sequences was
performed with NCBI's Ensembl interface. Mouse NMDA receptor
promoter sequences were compared with those of rat and human
genomic sequences for the conservation of the Sp binding motif.
2.3. Electrophoretic mobility shift and supershift assays
Electrophoretic mobility shift assays (EMSA) for possible Sp1, Sp3,
and Sp4 interactions with putative binding elements on all NMDA
receptor subunit promoters were carried out with a few modiﬁcations
from methods previously described [8]. Brieﬂy, based on in silico
analysis, oligonucleotide probes with putative Sp binding motifs on
each NMDA receptor subunit promoter were synthesized (Table 1A),
annealed, and labeled by a Klenow fragment (Invitrogen)ﬁll-in reaction
with [α-32P] dATP (50 μCi/200 ng; Perkin-Elmer, Shelton, CT, USA).Mouse primary visual cortical tissue and HeLa nuclear extract was
isolated using methods described previously [17]. Each labeled EMSA
probe was incubated with 2 μg of calf thymus DNA and 10 μg of
mouse cortical and/or 10 μg of HeLa nuclear extract. The probe reaction
was processed for EMSA. Supershift assayswere performedwith 1 μg of
Sp1, 3, or 4 speciﬁc antibody (Sp1, polyclonal rabbit antibody, H-225,
SC14027, Santa Cruz Biotechnology (SCBT), Santa Cruz, CA, USA; Sp3,
polyclonal rabbit antibody, H-225, SC13018, SCBT; Sp4, polyclonal
rabbit antibody, V-20, SC645, SCBT) added to the probe/nuclear extract
mixture and incubated for 20 min at 24 °C. When tested with western
blots usingmouse whole brain extract, the Sp1, Sp3, and Sp4 antibodies
gave two adjacent bands at the appropriate molecular weights corre-
sponding to the phosphorylated and non-phosphorylated forms of
these transcription factors. For competition, a 100-fold excess of
unlabeled oligonucleotides was incubated with the nuclear extract
before the addition of labeled oligonucleotides. Shift reactions were
loaded onto 4.5% polyacrylamide gel (58:1, Acrylamide:Bisacrylamide)
and run at 200 V for 3 h in 0.25× Tris–borate–EDTA buffer. Results
were visualized by autoradiography and exposed on ﬁlm. Mouse GM3
synthase with known Sp1 binding site was designed as previously
described [18] and used as a positive control. Sp1mutantswithmutated
sequences, as shown in Table 1B, were used as negative controls.
2.4. Chromatin immunoprecipitation (ChIP) assays in murine visual
cortical tissue
ChIP assays were performed similar to those described previously
[7]. Brieﬂy, 0.1 g of murine visual cortical tissue was used for each
immunoprecipitation reaction. From fresh murine brain, the visual
cortex was quickly dissected and cut into small pieces. The ﬁnely
chopped visual cortical tissue was ﬁxed with 2% formaldehyde for
20 min at 24 °C. Cells were then resuspended in swelling buffer
(5 mM PIPES, pH 8.0, 85 mM KCl, and 1% Nonidet P-40 (Sigma, St
Louis, MO, USA), with protease inhibitors added right before use) and
homogenized 10 times in a small pestle Dounce tissue homogenizer
(5 mL). Nuclei were then isolated by centrifugation before being
subjected to sonication in SDS lysis buffer (1% SDS, 10 mM EDTA,
50 mM Tris–HCl, pH 8.1 (Sigma)). The sonicated lysate was immuno-
precipitated with either 2 μg of Sp1 polyclonal rabbit antibody, 2 μg of
Sp3 polyclonal rabbit antibody, 2 μg of Sp4 polyclonal rabbit antibody,
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antibody (sc-6188, SCBT). Semi-quantitative PCR was performed using
1/20th of precipitated chromatin. Primers encompassing putative Sp1
binding sites near TSPs of NMDA receptor subunit genes (identiﬁed in
in silico analysis) were designed (Supplementary Table 1) as previously
described [10]. GM3 synthase and neurotrophin 3 promoters with known
Sp binding sites were used as positive controls [18,19], and β-actin
promoter was used as a negative control (Supplementary Table 1). PCR
reactions were carried out with DreamTaq polymerase (Thermo-Fisher
Scientiﬁc, Waltham, MA, USA). The use of cycling parameters and PCR
additives signiﬁcantly improved the quality and reproducibility of ChIP
and are listed in Supplementary Table 1. PCR products were visualized
on 2% agarose gels stained with ethidium bromide.
2.5. Construction and transfection of luciferase reporter vectors for promoter
mutagenesis study
Luciferase reporter constructs of Grin1, Grin2a, and Grin2b gene
promoters were made by PCR cloning their proximal promoter
sequences using genomic DNA prepared from mouse N2a cells as a
template. Digestion with restriction enzymes was performed,
followed by ligation of the product directionally into pGL3 basic
luciferase vector (E1751, Promega, Madison, WI, USA). Sequences
of primers used for PCR cloning and restriction enzymes used for
digestion are provided in Supplementary Table 2A. Site-directed muta-
tion of putative Sp binding sites on each promoter was generated using
QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA,
USA). Primers for mutagenesis are listed in Supplementary Table 2B.
All constructs were veriﬁed by sequencing.
Each promoter construct was transfected into N2a cells in a 24-well
plate using Lipofectamine 2000 (Invitrogen) and cell lysates harvested
after 48 h. Each well received 0.6 μg of reporter construct and
0.06 μg of pRL-TK renilla luciferase vector (E2241, Promega), a vector
with thymidine kinase promoter that constitutively expressed renilla
luciferase. Transfected neurons were stimulated with KCl at a ﬁnal
concentration of 20 mM in the culture media for 5 h as previously
described [20]. After 5 h of treatment, cell lysates were harvested and
measured for luciferase activity as described previously [20]. Data from
six independent transfections were averaged for each promoter
construct.
2.6. Plasmid construction of Sp1, Sp3, or Sp4 shRNA vectors, transfection,
and KCl treatment
Sp1 silencing was carried out using a combination of three to ﬁve
Sp1-speciﬁc 19–25 nt hairpin RNA (shRNA) against Sp1 (sc-29488,
SCBT). Sp3 and Sp4 silencing was carried out using speciﬁc shRNA
sequences against murine Sp3 and Sp4 that were cloned into the
pLKO.1 TRC cloning vector (Plasmid 10878, Addgene, Cambridge, MA,
USA). Target Sp3 and Sp4 shRNA sequences were chosen from the
RNAi Consortium's Public TRC Cloning Database at the Broad Institute
and are listed in Supplementary Table 3. The pLKO.1 non-mammalian
shRNA control vector, which contains a scrambled shRNA sequence
that targets no known mammalian genes, was used as the negative
control (SHC002, Sigma).
For transfection, N2a cells were plated at 60% conﬂuency in 6-well
dishes. Cells were co-transfected the day after plating with either the
Sp1, Sp3, or Sp4 shRNA constructs (3 μg) and turboGFP (1 μg) vectors
or the pLKO.1 non-mammalian control (3 μg) and the turboGFP (1 μg)
vector using 5 μL of JetPrime transfection reagent (PolyPlus Transfection,
Illkirch, France) per well. Puromycin at a ﬁnal concentration of 5 μg/mL
was added to the culture medium 1.5 days after transfection to select
for purely transfected cells. Green ﬂuorescence was observed tomonitor
transfection efﬁciency. Transfection efﬁciency for N2a cells was around
75%; however, puromycin selection effectively yielded 100% transfected
cells. N2a cells transfected with shRNA against Sp1, Sp3, and Sp4 werefurther stimulated with KCl at a ﬁnal concentration of 20 mM in the
culturemedia for 5 h as previously described [20]. After 5 h of treatment,
cells were harvested for RNA and protein isolation.
For transfection of primary neuronal cultures, disassociated neu-
rons were plated at a density of 2 × 105 cells/well and transfected
5 days post-plating with Sp1, Sp3, or Sp4 shRNA constructs (2 μg)
or the pLKO.1 non-mammalian control (2 μg) using 10 μL of
Neurofect transfection reagent per well. TurboGFP (0.5 μg) vector
was added to visualize transfection efﬁciency in each well. Transfec-
tion efﬁciency was around 40–50%; however, puromycin selection
effectively yielded 100% transfected cells.
2.7. Sp1, Sp3, and Sp4 over-expression and TTX treatment
The human Sp1, Sp3, and Sp4 cDNA clones were obtained fromOpen
Biosystems (Lafayette, CO, USA) and cloned into pcDNA Dest40 vector
using Gateway Multisite Cloning kit (Invitrogen) according to the
manufacturer's instructions and as described previously [15].
Transfection procedure for N2a cells and primary neuronal culture
was similar to that described above with the modiﬁcation that either
1.5 μg of Sp1, Sp3, and Sp4 over-expression vector, or 1 μg of the
pcDNA3.1 empty vector and 0.5 μg of turboGFP vector were used for
both N2a cells and primary neuronal cultures. Green ﬂuorescence was
used to monitor transfection efﬁciency. Transfected N2a cells were
impulse blocked for 3 days with TTX at a ﬁnal concentration of 0.4 μM
starting on the day after plating as previously described [20]. N2a cells
were harvested for RNA and protein isolation four days after transfec-
tion, whereas primary neuronal cultures were harvested 2 days after
transfection.
2.8. RNA isolation and cDNA synthesis
Total RNA was isolated using TRIZOL (Invitrogen) according to the
manufacturer's instructions. 1 μg of total RNA was treated with Dnase
I and the reaction stopped with heating at 65 °C in the presence of
EDTA. cDNA was synthesized using iScript cDNA synthesis kit (170-
8891, BioRad, Hercules, CA, USA) according to the manufacturer's
instructions.
2.9. Real-time quantitative PCR
Real-time quantitative PCR was carried out in a Cepheid Smart
Cycler Detection system (Cepheid, Sunnyvale, CA, USA) and/or the
iCycler System (BioRad) using the IQ Sybr Green SuperMix (170-8880,
BioRad) following the manufacturer's protocols and as described
previously. The primer sequences used are shown in Supplementary
Table 4. Primers were optimized to yield 95%–105% reaction efﬁciency
with PCR products run on agarose gel to verify the correct ampliﬁcation
length. Melt curve analyses veriﬁed the formation of a single desired
PCR product in each PCR reaction. Mouse β-actin for N2a and Gapdh
for primary neurons was used as internal controls, and the 2−ΔΔCT
method was applied to quantify the relative amount of transcripts.
2.10. Western blot analysis
KCl and TTX treatments, Sp1, Sp3, and Sp4 shRNA and over-
expression samples, along with appropriate controls, were harvested in
sample buffer (50 mM Tris–HCl pH 6.8, 1% SDS, 10% glycerol, 12.5 mM
EDTA). Nuclear extract from mouse cortical tissue, cultured primary
cortical neurons, N2a cells, and HeLa cells was extracted as described
for EMSA above. To load nuclear extract proportional to the cytoplasmic
volume, an equal amount of proteins from cytoplasmic extracts was
loaded for control and for KCl samples. Based on the ratio between
nuclear and cytoplasmic volumes for each of the samples, the propor-
tional amount of nuclear extract was loaded. Protein samples were
loaded onto 10% SDS-PAGE gel and electrophoretically transferred onto
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blocking, blots were incubated in primary antibodies against Sp1
(1:1000; Santa Cruz), Sp3 (1:1000; Santa Cruz), Sp4 (1:1000;
Santa Cruz), GluN1 (1:1000; Millipore Chemicon, Billerica, MA,
USA), GluN2A (1:600; 19953-1-AP, ProteinTech, Chicago, IL, USA),
and GluN2B (1:1000; 1498-NR2B, PhosphoSolutions, Aurora, CO,
USA). β-Actin (1:5000; Sigma) served as a loading control for cytoplas-
mic extracts and for Sp1, Sp3, and Sp4 shRNA and over-expression sam-
ples. TATA binding protein (1:1000; 1TBP18; Abcam; San Franscisco,
CA, USA) was the loading control to determine the relative levels of
Sp1, Sp3, and Sp4 in different cell types. NeuN (1:250; Millipore) was
used to determine nuclear contamination of cytoplasmic extracts.
Secondary antibodies used were goat-anti-rabbit and goat-anti-mouse
antibodies (Vector Laboratories, Burlingame, CA, USA). Blots were
then reacted with the ECL reagent (Pierce, Rockford, IL, USA) and
exposed to autoradiographic ﬁlm (RPI, Mount Prospect, IL, USA).
Quantitative analyses of relative changes were done with Gel Doc
(BioRad, Hercules, CA, USA).
2.11. Statistical analysis
Signiﬁcance among group means was determined by analysis of
variance (ANOVA). Signiﬁcance between two groups was analyzed by
Student's t-test. P-values of 0.05 or less were considered signiﬁcant.
3. Results
3.1. In silico analysis of the Grin1 and Grin2a–c proximal promoter regions
In silico analysis of the proximal promoters of murine NMDA recep-
tor subunit genes in the DNA sequence 1 kb upstream and 1 kb down-
stream of TSP revealed Sp binding motifs. The GC box motif (GGGCGG)
was found on the Grin1, Grin2a, and Grin2c promoters, and the GC box
with a tandem CT box (CCCTCC) was found on the Grin2b promoter
(see Table 1A for binding motifs).
3.2. Sp4 is prevalent in mouse visual cortical nuclear extract
Relative levels of Sp1, Sp3, and Sp4 in mouse visual cortical tissue,
N2a, and HeLa cells were probed with antibodies against each Sp factor.
Equal amounts of nuclear extracts were loaded and probed with Tata
box binding protein (TBP) as the loading control (Fig. 1A). The differ-
ence in the molecular weights between the samples corresponds to
the difference in the molecular weights of the protein in mice and
humans. As shown in Fig. 1A, Sp4 was present in greater amount in
mouse visual cortical tissue nuclear extract than in N2a cells and least
in HeLa cell nuclear extract. Sp3wasmost prevalent in HeLa cell nuclear
extract, less so in N2a cells and least in mouse visual cortical tissue
nuclear extract (Fig. 1A). The same was true for Sp1 (Fig. 1A). Further-
more, we found that N2a and HeLa cells contained smaller isoforms of
Sp1 (Fig. 1A, Sp1iso) [21] and Sp3 (Sp3si-3 and Sp3si-4) [22] that
were not present in mouse visual cortical tissue (Fig. 1A). Sp1 was
also found in its phosphorylated form in all nuclear lysates (Fig. 1A,
Sp1*) [23]. The slight downward shift of Sp1iso in N2a cells may be
due to post-translational modiﬁcation differences in mouse N2a and
human HeLa cancer cell lines (Fig. 1A).
3.3. In vitro binding of Sp4 to putative sites on the Grin1, Grin2a, and Grin2b
promoters
The electrophoretic mobility shift assays (EMSA) and supershift
assays were performed to determine Sp1, Sp3, and Sp4's ability to bind
its candidate site in vitro. GM3 synthase promoter with known Sp1
binding sites (2 tandem GC boxes) served as the positive control.
When incubated with mouse visual cortical tissue nuclear extract, GM3
synthase formed speciﬁc DNA/Sp3 and DNA/Sp4 shift and supershiftcomplexes (Fig. 1B, lanes 1 and 4 for Sp3, and 1 and 5 for Sp4, respec-
tively) but did not form a DNA/Sp1 shift or supershift complex
(Fig. 1B, lanes 1 and 3 respectively). We reasoned that the lack of Sp1
shift and supershift was due to insufﬁcient Sp1 in mouse cortical
nuclear extract. We, therefore, incubated GM3 synthase with HeLa
nuclear extract, which is known to contain Sp1 [18]. In the presence
of HeLa nuclear extract, GM3 synthase formed speciﬁc DNA/Sp1, DNA/
Sp3, and DNA/Sp4 shift and super shift complexes (Fig. 1B, lane 6 for
Sp1/Sp3/Sp4 shift, lanes 8, 9, and 10 for Sp1, Sp3, and Sp4 supershifts,
respectively). As Sp1 is capable of homotypic interactions that lead to
multimeric complexes [11], the higher supershift may be two Sp1
proteins bound to tandem Sp sites (Fig. 1B, lane 8, Sp1 Supershift*).
The supershift for Sp4 was faint in HeLa cells (Fig. 1B, lane 10), con-
sistent with reported neuronal distribution of Sp4 [14]. The shift
bands for visual cortical and HeLa nuclear extract were competed
out with the addition of cold competitor (Fig. 1B, lanes 2 and 7,
respectively).
Mouse visual cortical tissue nuclear extract incubated with putative
Sp sites on theGrin1, Grin2a, Grin2b, and Grin2c promoters gave positive
shift and supershift bands for Grin1, 2a, and 2b probes (Fig. 1C) but not
for the Grin2c probe (data not shown). Speciﬁcally, Sp3 and Sp4 shift
bands for Grin1, Grin2a, and Grin2b were observed (Fig. 1C, lanes 1, 8,
and 15, respectively) that were competed out by cold competitors
(Fig. 1C, lanes 2, 9, and 16). Supershift bands with Sp4 antibody were
present forGrin1,Grin2a, andGrin2b (Fig. 1C, lanes 5, 12, and 19, respec-
tively), whereas Sp1 and Sp3 bands were not present for Grin1 and
Grin2a, and were very faint for Grin2b (Fig. 1C, lanes 3, 4, 10, 11, 17,
and 18). An excess of unlabeled Grin1, Grin2b, and Grin3a probes with
mutated Sp binding sites was added to respective radiolabeled probes,
and they did not compete out the shift reactions (Fig. 1C, lanes 6, 13,
and 20, respectively). Shift reactions with mutated Sp sites on Grin1,
Grin2a, and Grin2b did not reveal Sp binding (Fig. 1C, lanes 7, 14, and
21, respectively).3.4. In vivo interactions of Sp4 with Grin1, Grin2a, and Grin2b promoters in
mouse visual cortex
The chromatin immunoprecipitation (ChIP) assay was performed
to verify Sp1, Sp3, and Sp4 protein interaction with the Grin1 and
Grin2a–c gene promoters in mouse visual cortical nuclear extract.
Brieﬂy, sonicated nuclear lysates from visual cortical tissue were
immunoprecipitated with Sp1, Sp3, or Sp4 antibody and the
resulting DNA was subjected to PCR analysis using primers sur-
rounding the putative Sp binding sites identiﬁed by in silico analysis.
As a control for the immunoprecipitation reaction, nerve growth
factor receptor (NGFR) antibody was used. To eliminate the possibility
of a bead-to-DNA interaction, an additional “no antibody” control was
used. As Sp factors regulate GM3 synthase [18], and Sp4 speciﬁcally
regulates neurotrophin 3 [19], primers against these gene promoters
were used as positive controls for the immunoprecipitation. Primers
in the coding region of β-actin that did not contain Sp binding sites
were used as a negative control. As a positive control for the PCR
reaction, 0.5% and 0.1% input DNAwere used. Parallel PCR ampliﬁcation
of all controls and the immunoprecipitated samples was done to
determine Sp factor binding.
As seen in Fig. 2, agarose gel analysis of PCR products revealed
speciﬁc bands for all input DNA controls. Furthermore, Sp4 immuno-
precipitated sample revealed an enriched band for GM3 synthase and
neurotrophin 3 positive controls, as well as for Grin1, Grin2a, and
Grin2b. An enriched band was not present for β-actin negative control
nor for Grin2c. Immunoprecipitated NGFR and “no antibody” negative
controls did not reveal enrichment in any gene regions tested. There
was also no enrichment of DNA above negative controls in the Sp1 or
Sp3 immunoprecipitated samples for any of the tested regions (data
not shown).
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Grin1, Grin2a, and Grin2b promoters that bound to Sp4 in vitro and
in vivo were each cloned into pGL3 basic luciferase vectors. Site-
directedmutations of the putative Sp4 binding sites identiﬁed by speciﬁc
EMSA shift and supershift reactions were constructed. Transfection of
control or mutated Sp promoter regions into N2a cells revealed a
signiﬁcant 34%, 38%, and 31% decrease in promoter activity of Grin1,
Grin2a, and Grin2b promoters containing themutated Sp4motif, respec-
tively (P b 0.001 for all, Fig. 3).Fig. 1. Relative levels of the Sp factors and In vitro binding of Sp factors to the GM3 synthase, Gr
nuclear extract frommouse visual cortical tissue, HeLa cell, and N2a cells were probed with Sp4
cortical tissue, and conversely, Sp3 and Sp1 levels were lowest inmouse cortical tissue as comp
isoforms of Sp1 (Sp1iso) and Sp3 (Sp3si-3 and Sp3si-4) not present inmouse cortical extract. Th
the loading control and showed similar levels in all nuclear extracts. B andC show in vitro bindin
with EMSA and supershift assays. 32P-labeled oligonucleotides, excess unlabeled oligos as com
nuclear extract, and Sp1, Sp3, or Sp4 antibodies are indicated by a “+” or a “−” sign. Arro
(B) GM3 synthase was used as a positive control with mouse cortical nuclear extract (B, lanes
revealed speciﬁc Sp1, 3, or 4 shift bands (B, lanes 1 and 6, respectively). The location of each
was added, it did not yield a band (B, lanes 2 and 7). The addition of Sp1 antibody yielded two s
of tandem Sp binding. The addition of Sp1 antibody did not yield speciﬁc supershift bands with
bands with both cortical and HeLa cell extract (B, lanes 4 and 9, respectively), as did the addition
withGrin1, 2a, or 2b probes yielded speciﬁc Sp1 and 3 shift bands (C, lanes 1, 8, and 15, respectiv
and 16, respectively). LabeledGrin1, 2a, or 2b probeswithmutant Sp sites didnot yield speciﬁc S
the respective Grin1, 2a, or 2b probes did not compete out the speciﬁc shift bands (C, lanes 6, 1
(C, lanes 3, 10, and 17). The addition of Sp3 antibody did not yield supershift bands for Grin1 or 2
of Sp4 antibody resulted in supershift bands for Grin1, 2a, and 2b (C, lanes 5, 12, and 19, respec3.6. Effect of mutated Sp4 binding sites on the response of Grin1, Grin2a,
and Grin2b promoters to KCl depolarizing treatment in N2a cells
To verify that Sp4 binding is necessary for the up-regulation of
Grin1, Grin2a, and Grin2b transcripts by KCl stimulation, N2a cells
with wild type or Sp4 mutated Grin promoters were subjected to
KCl depolarizing stimulation. As shown in Fig. 3, KCl induced
signiﬁcant increases of 44%, 50%, and 43% in the expression of
Grin1, Grin2a, and Grin2b promoters, respectively (P b 0.001 for
all). The activity-driven increase was abolished by mutating the
Sp4 binding site (Fig. 3), conﬁrming a requirement for Sp4 bindingin1, 2a, and 2b promoters. (A) To determine relative levels of Sp factors, equal amounts of
, Sp3, Sp1, or Tata box binding protein (TBP) antibodies. Sp4 levels were highest in mouse
ared to HeLa or N2a cells. In addition, HeLa and N2a cell nuclear extracts contained smaller
e phosphorylated form of Sp1was also found in all nuclear extracts (Sp1*). TBPwas used as
g of Sp factors to putative binding sites on the GM3 synthase, Grin1, 2a, 2b, and 2c promoters
petitors, excess unlabeled mutant Sp oligos as competitors, mouse visual cortical or HeLa
wheads indicate speciﬁc Sp1, Sp3, or Sp4 shift, supershift, and non-speciﬁc complexes.
1–5) or HeLa cell extract (B, lanes 6–10). Incubation with cortical or HeLa nuclear extract
band was clearly identiﬁed on shorter gel exposure. When excess unlabeled competitor
peciﬁc supershift bands for HeLa nuclear extract (B, lane 8) corresponding to the presence
cortical nuclear extract (B, lane 3). The addition of Sp3 antibody yielded speciﬁc supershift
of Sp4 antibody (B, lanes 5 and 10, respectively). (C) Incubation of cortical nuclear extract
ely). This shift bandwas competed outwith an excess addition of cold probes (C, lanes 2, 9,
p shift bands (C, lanes 7, 14, and21). The addition of unlabeledmutant competitor probes to
3, and 20). The addition of Sp1 antibody did not yield supershift bands for Grin1, 2a, or 2b
a (C, lanes 4 and 11, respectively) but did yield a band for Grin2b (C, lane 18). The addition
tively).
Fig. 2. In vivo ChIP assays for Sp4 interaction with NMDA receptor subunits in mouse visual cortical tissue. Chromatin was precipitated with anti Sp4 antibodies (Sp4 IP lane), anti-nerve
growth factor receptor p75 antibody (negative control, NGFR IP lane) or no antibody (negative control, noAb lane). Control reactions for PCRwereperformedwith 0.5% (input 0.5% IP lane)
and 0.1% (input 0.1% IP lane) of input chromatin.GM3 synthase and neurotrophin 3were used as positive controls, andβ-actinwas used as a negative control. Results indicate interactions of
Sp4 with Grin1, Grin2a, and Grin2b but not with Grin2c.
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Grin2a, and Grin2b transcripts.3.7. Effect of silencing Sp1, Sp3, and Sp4 on Grin1 and Grin2a–c in N2a cells
To determine the effect of silencing Sp1, Sp3, or Sp4 transcript on the
expression of GluN1, GluN2A, GluN2B, and GluN2C, a combination of 2–
5 plasmid vectors expressing small hairpin RNA (shRNA) against Sp1,
Sp3, or Sp4mRNA was used. Analysis of cDNAs of N2a cells transfected
with shRNA vectors was done using quantitative real-time PCR and
the 2−ΔΔCT method. β-Actin was used as the internal control. Silencing
of Sp4 resulted in signiﬁcant decreases of 68% in Sp4mRNA (P b 0.001,
Fig. 4A), and signiﬁcant decreases of 34%, 65%, and 78% in Grin1,
Grin2a and Grin2b mRNA levels, respectively (P b 0.01, P b 0.001, and
P b 0.001, respectively; Fig. 4B). With silencing, protein levels of Sp4
decreased signiﬁcantly to 56% (P b 0.01, Fig. 4C–D), and protein levels
of GluN1, GluN2A, and GluN2B signiﬁcantly decreased by 33%, 45%,
and 55%, respectively (P b 0.05, P b 0.01, and P b 0.01, respectively;Fig. 3. Site-directed mutational analysis of promoters of wild type (wt) and those with mutated
binding sites onGrin1, Grin2a, and Grin2b genes resulted in signiﬁcant decreases in luciferase ac
in the Grin1, Grin2a, and Grin2b promoters with mutated Sp sites. N = 6 for each construct. **
mutant + KCl are compared to mutants.Fig. 4E–F). mRNA levels of Grin2c did not change signiﬁcantly with
Sp4 silencing (Fig. 4B).
Silencing of Sp1 and Sp3 resulted in a 71% and 66% decrease in Sp1
and Sp3 mRNA levels, respectively (P b 0.001 for both, Fig. 4A), and a
63% and 52% in Sp1 and Sp3 protein levels, respectively (P b 0.01 for
both, Fig. 4C–D). However, silencing neither Sp1 nor Sp3 signiﬁcantly
changed mRNA levels of Grin1 and Grin2a–c (Fig. 4B), or protein levels
of GluN1, GluN2A, or GluN2B (Fig. 4E–F).
3.8. Effect of silencing Sp1, Sp3, and Sp4 on Grin1 and Grin2a–c in primary
neurons
To determine if the effect of silencing Sp factors, especially the lack of
an effect seen with silencing Sp1 and Sp3, was speciﬁc to N2a cells, we
transfected cultured primary mouse cortical neurons with the same
shRNAs aswe used for N2a cells.Gapdhwas used as the internal control.
In these neurons, the silencing of Sp4 resulted in a 64% decrease in
mRNA levels of Sp4 (P b 0.01, Fig. 4G), and a signiﬁcant 37%, 68%, and
63% decrease in mRNA levels of Grin1, Grin2a, and Grin2b, respectivelySp4 binding site (mut) for Grin1, Grin2a, and Grin2b genes in N2a cells. Mutating the Sp4
tivity. KCl depolarization signiﬁcantly increased promoter activity in all wild types, but not
*P b 0.001; X = NS. All mutants and wild type + KCl are compared to the wild type. All
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change was observed for Grin2c (Fig. 4H).
Silencing of Sp1 or Sp3 resulted in signiﬁcant decreases in Sp1 or Sp3
mRNA levels (51% and 57%, respectively, P b 0.05 and P b 0.01, respec-
tively, Fig. 4G), but did not signiﬁcantly change mRNA levels of Grin1,
Grin2a, Grin2b, and Grin2c (Fig. 4H).
3.9. Effect of over-expressing Sp1, Sp3, and Sp4 on Grin1 and Grin2a–c in
N2a Cells
To determine the effect of over-expressing Sp1, Sp3, or Sp4 on
transcript levels of Grin1 and Grin2a–c, plasmids over-expressing Sp1,Fig. 4. Effect of RNA interference-mediated silencing of Sp1, Sp3, or Sp4 on the expression of the
and Sp4 transcripts in N2a cells transfected with Sp1, Sp3, and Sp4 shRNA, respectively. N = 6. (
Sp3 or Sp1 shRNA. N = 6. (C–D)Western blots revealed a down-regulation of Sp4, Sp3, and Sp1
loading control and a representative blot is shown. N = 3. (E–F) Silencing of Sp4 reduced the
signiﬁcantly change these subunit levels. β-Actin served as a loading control. N = 3. (G) Prim
Sp4 transcript, respectively. N = 3. (H) mRNA levels of Grin1, Grin2a, and Grin2b were decrea
not decrease with Sp1, Sp3, or Sp4 shRNA in primary neurons. N = 3. *P b 0.01, **P b 0.01, andSp3, or Sp4 were transfected into N2a cells. β-Actin was used as the
internal control. Sp4 over-expression resulted in an approximately 30-
fold increase in Sp4 mRNA levels (P b 0.001, Fig. 5A), and signiﬁcant
increases by 53%, 152%, and 224% in mRNA levels of Grin1, Grin2a, and
Grin2b, respectively (P b 0.001 for all; Fig. 5B). mRNA levels of Grin2c
did not change signiﬁcantly (Fig. 5B). Sp4 over-expression led to a
signiﬁcant 132% increase in Sp4 protein levels (P b 0.01, Fig. 5C–D),
and signiﬁcant increases by 65%, 121%, and 102% in protein levels of
GluN1, GluN2A, and GluN2B, respectively (P b 0.05, P b 0.01, and
P b 0.01, respectively, Fig. 5E–F).
Sp1 or Sp3 over-expression led to a signiﬁcant 27 and 39-fold
increase in their respective mRNA levels (P b 0.001 for both; Fig. 5A),NMDA receptor subunit genes. (A) Real-time PCR revealed a down-regulation of Sp1, Sp3,
B) mRNA levels of Grin1, Grin2a, and Grin2bwere decreased with Sp4 shRNA but not with
proteins in Sp4, Sp3, and Sp1 shRNA-transfected N2a cells, respectively. β-Actin served as
protein levels of GluN1, GluN2A, and GluN2B, whereas silencing of Sp1 and Sp3 did not
ary neurons transfected with Sp1, Sp3, or Sp4 shRNA showed decreases in Sp1, Sp3, and
sed with Sp4 shRNA but not with Sp3 or Sp1 shRNA in primary neurons. Grin2c levels did
***P b 0.001.
Fig. 5. Effect of Sp1, Sp3, and Sp4 over-expression on the transcript and protein levels of NMDA receptor subunit genes. (A) Real-time PCR revealed an up-regulation of Sp1, Sp3, and Sp4
transcripts in N2a cells transfectedwith Sp1, Sp3, and Sp4 over-expression vectors, respectively. N = 6. (B)mRNA levels of Grin1, Grin2a, and Grin2bwere increasedwith Sp4 over-expression
butnotwith Sp3or Sp1over-expression.N = 6. (C–D)Westernblots revealed anup-regulationof Sp4, Sp3, and Sp1proteinwith Sp4, Sp3, and Sp1over-expression, respectively, inN2a cells.β-
Actin served as a loading control and a representative blot is shown. N = 3. (E–F) Over-expression of Sp4 increased protein levels of GluN1, GluN2A, and GluN2B, whereas over-expression of
Sp1 and Sp3 did not signiﬁcantly change these subunit levels. β-Actin served as a loading control. N = 3. (G) Primary neurons transfected with Sp1, Sp3, or Sp4 over-expression showed
increases in Sp1, Sp3, and Sp4 transcripts, respectively. N = 3. (H) mRNA levels of Grin1, Grin2a, and Grin2bwere increased with Sp4 over-expression but not with Sp3 or Sp1 over-expression
in primary neurons. Grin2c levels did not increase with Sp1, Sp3, or Sp4 over-expression in primary neurons. N = 3. *P b 0.01, **P b 0.01, and ***P b 0.001.
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levels (P b 0.01 and P b 0.05, respectively, Fig. 5C–D). However, over-
expression of Sp1 or Sp3 did not signiﬁcantly change mRNA levels of
Grin1 and Grin2a–c (Fig. 5B) or protein levels of GluN1, GluN2A, and
GluN2B (Fig. 5E–F).
3.10. Effect of over-expressing Sp1, Sp3, and Sp4 on Grin1 and Grin2a–c in
primary neurons
To determinewhether the lack of an effect seenwith over-expression
of Sp1 and Sp3 was restricted to N2a cells, cultured primary mouse
cortical neurons were transfected with Sp1, Sp3, or Sp4 over-expressionvectors. Gapdh was used as the internal control. Over-expression of Sp4
in cultured mouse cortical neurons resulted in a 29-fold increase in
mRNA levels of Sp4 (P b 0.01, Fig. 5G), with a 203%, 231%, and 241%
increase in mRNA levels of Grin1, Grin2a, and Grin2b, respectively
(P b 0.01 for all; Fig. 5H). Grin2c levels were not changed by Sp4 over-
expression (Fig. 5H).
Over-expression of Sp1 or Sp3 resulted in a signiﬁcant 63 and 31-fold
increase in their respectivemRNA levels (P b 0.01 for both; Fig. 5G), and
signiﬁcant changes in mRNA levels of Grin1, Grin2a, and Grin2b
(Fig. 5H), but not Grin2c (Fig. 5H). The increase in mRNA levels of
Grin1, Grin2a, and Grin2b with Sp1 and Sp3 over-expression was
signiﬁcantly less than that seen with Sp4 over-expression.
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Grin2a, and Grin2b transcripts in N2a Cells
We have previously shown that NMDA receptor subunits are up-
regulated in response to physiological concentrations of KCl, a
depolarizing agent that increases neuronal activity [6]. To determine if
the Sp factors are necessary for this up-regulation, control N2a cells
and cells transfected with Sp1, Sp3, or Sp4 shRNA were subjected to
20 mMKCl for 5 h. As seen in Fig. 6A, KCl depolarization signiﬁcantly in-
creased Grin1, Grin2a, and Grin2b transcript levels by 125%, 138%, and
154%, respectively (P b 0.001 for all). In the presence of Sp4 shRNA,
KCl failed to increase transcript levels of Grin1, Grin2a, and Grin2b
(Fig. 6A). On the other hand, Sp1 or Sp3 shRNA did not prevent
activity-mediated increases inGrin1,Grin2a, andGrin2b transcript levels
(Fig. 6A). Transcript levels of Grin2c increased signiﬁcantly with KCl
treatment (P b 0.001; Fig. 6A) but was not signiﬁcantly changed in the
presence of Sp1, Sp3, or Sp4 shRNA (Fig. 6A).
3.12. Over-expression of Sp4 rescued the TTX-mediated down-regulation of
Grin1, Grin2a, and Grin2b in N2a cells
Our laboratory has shown previously that NMDA receptor subunit
transcript levels are down-regulated in response to 0.4 μM TTX [6]. To
determine if over-expression of Sp factors can rescue NMDA receptor
subunit transcript levels suppressed by TTX-induced impulse blockade,
control N2a cells and cells transfected with Sp1, Sp3, or Sp4 over-
expression vectors were subjected to 0.4 μM TTX treatment for 3 days.
Control cells exposed to TTX showed a signiﬁcant decrease of 21%,
63%, and52% in transcript levels ofGrin1,Grin2a, andGrin2b, respective-
ly (P b 0.01, P b 0.001, and P b 0.001, respectively; Fig. 6B). Cells that
were transfected with Sp4 over-expression vectors rescued the down-
regulation seen with TTX treatment, with an increase in Grin1, Grin2a,
and Grin2b transcript levels of 42%, 86%, and 78%, respectively, as com-
pared to controls (P b 0.001 for all as compared to TTX alone; Fig. 6B).
Grin2c transcript level decreased signiﬁcantly with TTX treatment
(P b 0.001, Fig. 6B) but was not rescued with Sp4 over-expression
(Fig. 6B). Over-expression of Sp1 or Sp3 did not rescue the TTX-
mediated decrease in transcript levels of Grin1, Grin2a, Grin2b, and
Grin2c (Fig. 6B).
3.13. Effect of KCl and TTX on Sp4 levels in primary neurons
To determine if Sp4 itself is regulated by neuronal activity, we
analyzed its protein levels in the presence of KCl or TTX. As shown in
Fig. 6C–D, Sp4 protein levels increased signiﬁcantly by 33% with 5 h of
KCl depolarizing treatment (P b 0.01) and decreased signiﬁcantly by
26% (P b 0.05) with 0.4 μM TTX treatment in primary neurons.
To determine if increased Sp4 expression seen with KCl treatment
represents new synthesis and nuclear translocation of Sp4, we
harvested the nuclear and cytoplasmic fractions from cultured mouse
cortical neurons treated with and without KCl. We loaded an equal
amount of cytoplasmic extract for both control and treated cells. We
also loaded an equal amount of nuclear extracts proportional to the
cytoplasmic volume for both control and treated cells. β-Actin was
used as the cytoplasmic loading control. Its absence in the nuclear frac-
tion indicated that the fraction was free of cytoplasmic contamination
(Fig. 6E). NeuN, a neuronal DNA binding protein and nuclear marker,
was present in the nuclear fraction only (Fig. 6E), indicating that the
cytoplasmic fraction was free of nuclear contamination. The intensity
of NeuN did not change signiﬁcantly with KCl treatment (data not
shown).
Depolarizing treatment led to a signiﬁcant 54% increase in Sp4
protein in the nuclear fraction as compared to controls (P b 0.01,
Fig. 6E–F), whereas the cytoplasmic fraction of Sp4was not signiﬁcantly
changed (Fig. 6E–F). This indicates that there was new synthesis and
nuclear translocation of Sp4 in primary neurons. On the other hand,depolarizing treatment did not lead to a signiﬁcant increase in the
cytoplasmic or nuclear fractions of Sp1 or Sp3.
3.14. Homology
The functional Sp binding sites are conserved among mice, rats, and
humans for Grin1, Grin2a, and Grin2b (Fig. 7).
4. Discussion
Using multiple approaches, including EMSA and supershift assays,
ChIP in primary visual cortical tissue, promoter mutational analysis,
over-expression and knock-down experiments, the present study docu-
ments for the ﬁrst time that speciﬁcity protein 4 (Sp4) functionally
regulates the expression of NMDA receptor subunits GluN1, GluN2A,
and GluN2B (Grin1, Grin2a, and Grin2b, respectively). Moreover,
silencing Sp4 prevented the up-regulation of Grin1, Grin2a, and
Grin2b mRNA levels induced by depolarizing stimulation, whereas
over-expressing Sp4 rescued mRNA levels suppressed by TTX-
induced impulse blockade. The Sp regulatory sites tested in this
study are conserved among mice, rats, and/or humans.
The NMDA receptor is a family of glutamatergic receptors that
mediate the majority of excitatory neurotransmission in the brain.
They are voltage-dependent, ligand-gated, heterotetrameric ion chan-
nels composed of GluN1 in various combinations with GluN2A–D and/
or GluN3A–B subunits [1]. When activated, NMDA receptors exhibit a
relatively higher permeability to Ca2+ ion than the AMPA or kainite
excitatory receptors [24]. NMDA receptors are functionally linked to a
variety of normal neuronal processes, including neural development,
plasticity, learning, and memory [25–27]. However, with excessive
Ca2+ inﬂux, NMDA receptors are implicated in neuropathological
conditions, such as excitotoxicity andmanyneurodegenerative diseases
[28]. Thus, the proper regulation of NMDA receptors is crucial for the
health and survival of neurons in the CNS.
Sp4 is in the speciﬁcity protein/Krüppel-like (SP/KLF) family of zinc
ﬁnger transcription factors that bind to GC-rich sequences of DNA
(for review see [11]). The SP/KLF family currently has 25 members
and, of these, Sp4 is structurally most similar to speciﬁcity proteins 1
(Sp1) and 3 (Sp3) [11]. Sp4, Sp3, and Sp1 share critical amino acid
homology in their DNA binding domains and compete for the same
cis- elements [11]. Unlike Sp1 and Sp3, whose expression is ubiquitous,
Sp4 is found primarily in the brain and testes, and its neuronal expres-
sion increases with development [14]. Hypomorphic Sp4 mice have
vacuolization in the hippocampal gray matter and deﬁcits in both
sensorimotor gating and contextualmemory. Restoration of Sp4 rescues
all observable molecular, histological, and behavioral abnormalities in
these mice [29]. Sp4-null male mice do not breed but have a normal
reproductive system, suggesting a possible deﬁcit in the nervous
system [14].
The present study has found that Sp4 exists in greater abundance
in the murine brain than in N2a or HeLa cells, whereas the opposite
is true for Sp1 and Sp3. Furthermore, mRNA and protein levels of
Sp4 are higher than that of Sp1 in primary neurons [30]. On the
other hand, Sp1 and Sp3, but not Sp4, are highly expressed in glial
cells [30]. Consistent with these ﬁndings is our discovery that it is
Sp4, not Sp1 or Sp3, that regulates the expression of Grin1, Grin2a,
and Grin2b in neurons. N2a cells possess smaller isoforms of Sp1
and Sp3 that are not present in primary neurons (see Fig. 1A). The
smaller isoforms of Sp3 are known to act as transcriptional repres-
sors and the same may be true for Sp1 [22]. In the absence of the
smaller isoforms, primary neurons over-expressing the exogenous
full length Sp3 or Sp1 may be activated to express their target
genes, whereas such activation was not seen in N2a cells (Fig. 5H
and B).
Of theNMDA receptor subunits, GluN1 is obligatory to the formation
of a functional receptor. This subunit binds to the co-agonist glycine,
Fig. 6. Effect of increased or decreased neuronal activity on Sp factors and on target genes in the presence of Sp1, Sp3, or Sp4 silencing or over-expression. (A) N2a cells treated for 5 hwith
20 mM KCl revealed an up-regulation of all transcripts as compared to controls. In the presence of Sp4 silencing, 5 h treatment with 20 mM KCl failed to up-regulate the transcripts of
Grin1, Grin2a, and Grin2b, but had no effect on Grin2c. Sp3 and Sp1 silencing did not prevent KCl-induced up-regulation of Grin1 and Grin2a–c subunits. N = 6. (B) N2a cells treated
for 3 days with 0.4 μM TTX revealed a down-regulation of Grin1 and Grin2a–c subunits as compared to controls. Over-expression of Sp4 rescued the down-regulation of the Grin1,
Grin2a, and Grin2b transcripts, but not that of Grin2c. Over-expression of Sp1 or Sp3 did not rescue the down-regulation of Grin1 and Grin2a–c transcripts seen with KCl treatment.
N = 6. (C–D) KCl-induced activity increased protein levels of Sp4, whereas TTX-induced impulse blockade decreased Sp4 protein levels in primary neurons. N = 3. (E–F) Increased
neuronal activity led to an increase in the nuclear Sp4 but not cytoplasmic Sp4. Nuclear and cytoplasmic levels of Sp1 and Sp3 did not change signiﬁcantly. β-Actin served as a loading
control and indicated no cytoplasmic contamination of the nuclear fraction. NeuN was present only in the nucleus and indicated no nuclear contamination of the cytoplasmic fraction.
N = 3. *P b 0.01, **P b 0.01, and ***P b 0.001; (A–B) ###P b 0.001 and X = non-signiﬁcant when compared to KCl- or TTX-treated samples.
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both pre- and postnatal brains [5]. Although a binding site for Sp1 was
previously reported but not characterized on the Grin1 promoter
[1,31], our present study documents that it is Sp4, and not Sp1, that
exerts such functional regulation in neurons.Fig. 7. Aligned partial sequences of Grin1, Grin2a, and Grin2b promoters from mouse, rat,
and human showed conserved Sp binding sites.TheGluN2A–D subunits each binds to the agonist glutamate [5].Most
NMDA receptors in the CNS are composed of twoGluN1 and twoGluN2A
or two GluN2B subunits [3]. The expression of GluN1/GluN2A receptors
is limited in the neonate but becomes prominent in the adult, whereas
the expression GluN1/GluN2B receptors is prominent in both the
neonate and adult [32]. The GluN1/GluN2A receptors confer a lower
afﬁnity for glutamate and faster channel kinetics than the GluN1/
GluN2B receptors [2]. In the adult, the GluN1/GluN2A receptors are
prevalent at synaptic sites, whereas the GluN1/GluN2B receptors domi-
nate extra-synaptically, with each receptor subtype playing distinct
roles in the coupling to intracellular signaling cascades, synaptic
plasticity, and cell death [33–35]. The role of GluN1/GluN2A receptors
in synaptic plasticity, whether long term potentiation or long term
depression, or the location and conditions under which GluN2A plays a
role, is still debated [35–38].
The GluN1/GluN2B receptor has higher afﬁnity for the signaling
protein CaMKII than GluN1/GluN2A, interacting directly with CaMKII
to modulate synaptic plasticity, learning, and memory [39]. Upon
activation, GluN1/GluN2B receptors allow for the entry of large amounts
of cations, particularly Ca2+, which is responsible for its functional role
in neuronal plasticity, especially long term potentiation, as well as
its role in learning and memory [25,27]. When activated in excess,
Fig. 8.Amechanistic scheme of transcriptional co-regulation by Sp4, NRF-1, and NRF-2. The
three factors co-regulate Grin1 and Grin2b in a concurrent and parallel (same direction)
manner, but only Sp4 regulates Grin2a, hence via a complementary mechanism.
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and cell death [40]. The regulation of GluN2B is critical for neuronal
health, with GluN2B knockout mice dying at birth. On the other hand,
GluN2A knockout mice are viable, though possessing neurological
deﬁcits [24]. The present study shows for the ﬁrst time that it is Sp4,
and not Sp1 as previously postulated [41,42], that regulates both
GluN2A and GluN2B in neurons.
mRNA levels of GluN1, GluN2A, and GluN2B change in response to
perturbations in neuronal activity. Speciﬁcally, increasing neuronal
activity by KCl-induced depolarization or decreasing neuronal activity
by the action potential blocker TTX causes parallel changes in Grin1,
Grin2a, and Grin2b ([6] and the present study). Sp4 itself responds to
depolarizing stimulation with its own new synthesis and translocation
to the nucleus [the present study], consistent with our hypothesis that
Sp4 activates its target genes, Grin1, Grin2a, and Grin2b, in an activity-
dependent manner. However, under extreme conditions, such as an
hour of excitotoxic insult, Sp4 degrades via a calpain-mediated pathway
[30]. With excitotoxicity, synaptic GluN1/GluN2A receptors confer
neuroprotection through the activation of an Akt- or ERK-dependent
anti-apoptotic signaling pathway [43]. Extra-synaptic GluN1/GluN2B
receptors, however, are pro-apoptotic [43].We propose that Sp4 closely
regulates the expression of GluN1, GluN2A, and GluN2B receptor
subunits under physiological conditions of neuronal activity, but that
under excitotoxic conditions, Sp4 itself is degraded, thereby down-
regulating all of its target genes, especially the neuroprotective
GluN2A subunit.
The GluN2C and 2D subunits are developmentally and regionally
expressed, and relatively little is known about their functions [5].
The GluN3A and 3B subunits bind glycine, but like GluN2C and 2D,
are thought to be regionally and developmentally expressed [44].
The present study indicates that GluN2C is not regulated by Sp4,
Sp3, nor Sp1. The other subunits are beyond the scope of this study.
Neuronal activity is a highly energy demanding process, and it is
coupled to energy metabolism at the cellular level [45]. Recently, we
found that this coupling extends to the molecular level in that the
same transcription factors, nuclear respiratory factor 1 (NRF-1) and 2
(NRF-2), each co-regulates mediators of energy metabolism and neuro-
nal activity. Both NRF-1 and NRF-2 co-regulate the GluN1 and GluN2B
subunits of the NDMA receptor [6,7] as well as all 13 subunits of
cytochrome c oxidase (COX) [9,10], the terminal enzyme of the
mitochondrial electron transport chain critical for energy generation in
neurons. The present study documents that Sp4 regulates the GluN1,
GluN2A, and GluN2B subunits of the NDMA receptor. Sp1 factor has
also been found recently to regulate all 13 subunits of COX [15]. Thus,
Sp factors can also mediate the coupling of neuronal activity with
energy metabolism. Of the three mechanisms possible for Sp4's regula-
tion of the NMDA receptor subunit genes with respect to NRF-1 and
NRF-2: complementary, concurrent and parallel, and a combination of
complementary and concurrent/parallel, the present results are consis-
tent with a combination of the complementary and concurrent/parallel
mechanism: complementary for Grin2a, and concurrent/parallel for
Grin1 and Grin2b (Fig. 8).
A possible beneﬁt of a combination of complementary and
concurrent/parallel mechanism is that the critical GluN1 and
GluN2B subunits are regulated by multiple transcription factors,
but that there is a differential regulation for GluN2A. It is likely
that Sp4, NRF-2, and NRF-1 transcription factors play different and
non-redundant roles in mediating the tight coupling of neuronal
activity and energy metabolism under different conditions. Other
transcription factors or transcription co-activators may also be
involved. Future studies will be directed at these issues.
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